| Investor Type | Firm |
| Type of Fund | Corporate VC |
| Stages | Seed |
| Investing | Canada • Israel |
LEO Foundation is a Denmark-based Corporate Venture Capital fund with a focus on seed-stage investments. The fund operates primarily as a philanthropic entity dedicated to supporting the amelioration of skin diseases and improving the lives of people affected by them. They achieve this through grant-making activities and maintaining engaged ownership of their investments.
The Foundation takes pride in paving the way for skin disease cures, propelled by their slogan, 'Let's pave the way for curing skin diseases.' They offer grants to support pioneering research and initiatives that encourage public and youth interest in science, especially within the field of dermatology.
Each year, they fund numerous skin research projects, as detailed in their news and press releases, underscoring their commitment to driving advances in this area of medical science.
Their investment strategy is not only philanthropic but also responsible, reflecting their values of sustainability, diversity, equity, and inclusion. In addition to the grant-making, LEO Foundation carries out engaged ownership across different business activities, including direct ownership of LEO Pharma and investments through LEO Group Investments and LEO Holding.
Their approach to ownership is principled and they highlight the importance of responsible investments. They emphasize their organizational values, history, and the impact they aim to make through their purpose, ambitions, and strategies. Further details about their funding activities, governance structure, tax practices, and sustainability approach can be found in their annual reports and publications, which are accessible through their website.









